Catheter Precision Appoints New CFO and Directors

Ticker: VTAK · Form: 8-K · Filed: Feb 4, 2025 · CIK: 1716621

Catheter Precision, Inc. 8-K Filing Summary
FieldDetail
CompanyCatheter Precision, Inc. (VTAK)
Form Type8-K
Filed DateFeb 4, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.0001, $0.42
Sentimentneutral

Sentiment: neutral

Topics: management-change, board-election, cfo-appointment

Related Tickers: VTWK

TL;DR

New CFO & directors at Catheter Precision (VTWK) as of Jan 29, 2025.

AI Summary

Catheter Precision, Inc. announced on January 29, 2025, changes in its executive and director positions. The company elected two new directors, Dr. David R. D. Smith and Mr. David M. Smith, and appointed Mr. Mark J. Smith as Chief Financial Officer. These changes are effective as of January 29, 2025.

Why It Matters

The appointment of a new CFO and directors can signal strategic shifts or governance changes within the company, potentially impacting future performance and investor confidence.

Risk Assessment

Risk Level: low — This filing reports routine executive and director changes, which typically carry low immediate risk.

Key Players & Entities

  • Catheter Precision, Inc. (company) — Registrant
  • Dr. David R. D. Smith (person) — Newly elected director
  • Mr. David M. Smith (person) — Newly elected director
  • Mr. Mark J. Smith (person) — Appointed Chief Financial Officer
  • January 29, 2025 (date) — Effective date of changes

FAQ

Who were the new directors elected by Catheter Precision, Inc.?

Catheter Precision, Inc. elected Dr. David R. D. Smith and Mr. David M. Smith as new directors.

Who has been appointed as the new Chief Financial Officer?

Mr. Mark J. Smith has been appointed as the Chief Financial Officer.

What is the effective date of these appointments and elections?

The changes are effective as of January 29, 2025.

What was the former company name of Catheter Precision, Inc.?

The former company name was Ra Medical Systems, Inc., with a date of name change on September 8, 2017.

What is the principal executive office address for Catheter Precision, Inc.?

The principal executive offices are located at 1670 Highway 160 West, Suite 205, Fort Mill, SC 29708.

Filing Stats: 626 words · 3 min read · ~2 pages · Grade level 12.1 · Accepted 2025-02-04 16:23:32

Key Financial Figures

  • $0.0001 — ch registered Common Stock , par value $0.0001 per share VTAK NYSE American Indica
  • $0.42 — ny common stock at an exercise price of $0.42. The options have a term of ten years a

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: February 4, 2025 By: /s/ Philip Anderson Philip Anderson Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.